Advertisement

The Scientist

» immunology, disease/medicine and microbiology

Most Recent

image: Down and Dirty

Down and Dirty

By | September 1, 2012

Diverse plant communities create a disease-fighting "soil genotype."

3 Comments

image: Pleasant to the Touch

Pleasant to the Touch

By | September 1, 2012

Scientists hope an understanding of nerve fibers responsive only to gentle touch will give insight into the role the sense plays in social bonding.

0 Comments

image: Opinion: Younger Is Better

Opinion: Younger Is Better

By | August 31, 2012

Stem cells collected from younger donors are more effective for transplantation and regenerative medicine than those from older individuals.

9 Comments

image: Soil Harbors Antibiotic Resistance

Soil Harbors Antibiotic Resistance

By | August 30, 2012

Identical resistance genes in soil and clinical bacteria hint at dangerous genetic arms trade that is aggravating the antibiotic-resistance crisis.

4 Comments

image: Resisting TB

Resisting TB

By | August 30, 2012

A study finds that drug-resistant tuberculosis is more prevalent than current estimates suggest.

0 Comments

image: The Danger of Vaccine Exemptions

The Danger of Vaccine Exemptions

By | August 30, 2012

Are states with less rigorous rules about which children can claim an exception from vaccination in kindergarten putting communities at higher risk of childhood disease?

4 Comments

image: Dieting Monkeys Don't Live Longer

Dieting Monkeys Don't Live Longer

By | August 29, 2012

The latest news from a long-term study of calorie restriction in rhesus macaques shows better health, but no boost in lifespan, in monkeys who eat less.

11 Comments

image: Boston to Test Bioterror Sensors

Boston to Test Bioterror Sensors

By | August 29, 2012

Federal officials will release harmless bacteria into subway tunnels beneath the Northeastern city to test new sensors designed to detect biological agents.

8 Comments

image: Epigenetic Drug Improves Cholesterol Levels

Epigenetic Drug Improves Cholesterol Levels

By | August 28, 2012

Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.

1 Comment

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

Advertisement
RayBiotech
RayBiotech

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
Shimadzu Scientific
Shimadzu Scientific
Advertisement
The Scientist